Breaking News

BASi Restructures, Appoints Interim CEO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi (Bioanalytical Systems, Inc.) has reorganized its U.S. operations as part of its ongoing plan to reduce expenses, improve customer service and increase profitability. In addition to the realignment of operational and administrative responsibilities to increase efficiency, the company has implemented a workforce reduction aimed at reducing costs. Through attrition and layoffs that occurred during the past 60 days, including those made today, BASi has reduced its workforce by 12%. The company...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters